Physician profile
Gavin H Smith
NPI 1427019868
$4,047.49
in general payments reported to CMS, 2019-2025
24 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $681 · 2021: $893 · 2022: $735 · 2023: $347 · 2024: $243 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,036.71 | 2019-2022 | |
| Zimvie INC. | $722.60 | 2022-2023 | |
| Polynovo North America LLC | $213.85 | 2023-2025 | Novosorb Btm |
| Paragon 28, INC. | $195.64 | 2023-2025 | Portfolio, Precision Guide Lapidus, Bun-Yo-Matic |
| Sonex Health, INC. | $143.70 | 2025 | Sx-One Microknife |
| Linvatec Corporation | $67.41 | 2022-2025 | Biobrace 23mm, Livatec Knee Preservation System, Linvatec Shoulder Arthroscopy |
| Avanos Medical | $62.90 | 2021-2025 | On-Q Pump and Accessories |
| Orthofix Medical, INC. | $57.29 | 2019-2024 | Physio-Stim |
| Smith+Nephew, INC. | $53.43 | 2020-2024 | Renasys Go V2 Home |
| Fusion Orthopedics USA, LLC | $47.41 | 2025 | |
| Depuy Synthes Sales INC. | $47.20 | 2024-2025 | Motoband, Hammerlock, Foot Osteotomy Wedge System |
| Treace Medical Concepts, INC. | $45.69 | 2022-2024 | |
| Bioventus LLC | $43.20 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $40.74 | 2025 | Evenity, Prolia |
| Pacira Therapeutics, INC. | $36.82 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $36.62 | 2025 | Variax, Pangea, Easyfuse |
| Heron Therapeutics, INC. | $35.78 | 2021-2023 | Aponvie |
| Averitas Pharma INC. | $29.99 | 2024 | Qutenza |
| Fidia Pharma USA INC. | $25.21 | 2025 | Hymovis, Triluron |
| Davol INC. | $23.76 | 2022 | |
| Organogenesis INC. | $23.32 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $21.72 | 2025 | |
| Ethicon US, LLC | $19.41 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.09 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.